Supply and Manufacturing Agreement Sample Contracts
SUPPLY AND MANUFACTURING AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND TRIANGLE PHARMACEUTICALS, INC.Supply and Manufacturing Agreement • September 19th, 2002 • Triangle Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Standard Contracts
EX-10.14.1 28 a2233678zex-10_141.htm EX-10.14.1 Execution Version SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • May 5th, 2020 • Delaware
This SUPPLY AND MANUFACTURING AGREEMENT (this “Agreement”) is made by and between STRATEC Biomedical AG (formerly STRATEC Biomedical Systems AG), a stock corporation formed under the laws of the Federal Republic of Germany, having its principal place of business at Gewerbestrasse 37, D-75217 Birkenfeld-Graefenhausen, Germany (“STRATEC”) and Quanterix Corporation, One Kendall Square, Suite B14201, Cambridge, MA 02139 (hereinafter referred to as “QTX”, and both STRATEC and QTX are referred to as the Parties). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed thereto in the Development Agreement (as defined below).
FIRST AMENDMENT TO SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • November 9th, 2017 • Quanterix Corp • Laboratory analytical instruments
THIS AMENDMENT (the “Amendment”) is made and entered into effective as of October 17, 2013, by and between QUANTERIX CORPORATION, a company organized and existing pursuant to the laws of Delaware, U.S.A. (“QTX”), and STRATEC BIOMEDICAL AG, a company organized and existing pursuant to the laws of the Federal Republic of Germany (“STRATEC”). QTX and STRATEC each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • November 4th, 2021 • Arcutis Biotherapeutics, Inc. • Pharmaceutical preparations • Delaware
This Supply and Manufacturing Agreement (the “Agreement”) is made as of this 15th day of September 2021 (the “Effective Date”) by and between DPT Laboratories, Ltd., a Texas Limited Partnership with a place of business at 307 East Josephine Street, San Antonio, Texas 78215 (hereinafter “DPT”) and Arcutis Biotherapeutics, Inc., a Delaware corporation having principal offices at 3027 Townsgate Road, Suite 300, Westlake Village, California 91361 (“COMPANY”). COMPANY and DPT may be referred to herein by name or individually, as a “Party” and collectively, as the “Parties.”
SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • June 5th, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
As of December 16, 2014 ("Effective Date") between QIAGEN Inc., a California corporation having its principal office at 19300 Germantown Road, Germantown, MD 20874 ("QIAGEN"), and ArcherDX, Inc., a Delaware corporation ("ArcherDX") having its principal office at Flatiron Park West, Building B, 2477 55th Street, Suite 202, Boulder, CO 80301; QIAGEN and ArcherDX also referred to as "Party" and jointly as "Parties".
SECOND AMENDMENT TO SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • February 22nd, 2022 • Cerus Corp • Surgical & medical instruments & apparatus
This Second Amendment (“Second Amendment”) to the Supply and Manufacturing Agreement dated April 1, 2017 between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”) as previously amended (the “Agreement”) is made this 21st day of December 2021 (the “Amendment Effective Date”).
ContractSupply and Manufacturing Agreement • March 8th, 2017 • Cerus Corp • Surgical & medical instruments & apparatus
This Amendment #4 (this “Amendment”) to that certain Supply and Manufacturing Agreement, dated March 1, 2008, by and between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”), as amended on November 28, 2012, December 23, 2014 and December 20, 2016 (together, the “Amendments”) (as amended by the Amendments, the “Agreement”), is made effective as of January 31, 2017. Capitalized terms used herein and not otherwise defined shall have the meanings set forth therefor in the Agreement.
Fourth Amendment To Supply and Manufacturing AgreementSupply and Manufacturing Agreement • March 2nd, 2015 • Endo International PLC • Pharmaceutical preparations
THIS FOURTH AMENDMENT, dated as of this 25th day of February, 2015, is by and between Teikoku Seiyaku Co., Ltd./Teikoku Pharma USA, Inc. (collectively, “TEIKOKU”) and ENDO PHARMACEUTICALS INC. (“ENDO”).
ContractSupply and Manufacturing Agreement • May 4th, 2017 • Cerus Corp • Surgical & medical instruments & apparatus
This Amendment #5 (this “Amendment”) to that certain Supply and Manufacturing Agreement, dated March 1, 2008, by and between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”), as amended on November 28, 2012, December 23, 2014, December 20, 2016 and January 31, 2017 (together, the “Amendments”) (as amended by the Amendments, the “Agreement”), is made effective as of March 3, 2017. Capitalized terms used herein and not otherwise defined shall have the meanings set forth therefor in the Agreement.
Fifth Amendment To Supply and Manufacturing AgreementSupply and Manufacturing Agreement • November 9th, 2017 • Endo International PLC • Pharmaceutical preparations
THIS FIFTH AMENDMENT, dated as of this 19th day of July, 2017, is by and among Teikoku Seiyaku Co., Ltd./Teikoku Pharma USA, Inc. (collectively, “TEIKOKU”) and ENDO VENTURES LIMITED (“ENDO”) and ENDO PHARMACEUTICALS INC. (“EPI”).
SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • May 6th, 2008 • Cerus Corp • Surgical & medical instruments & apparatus • New York
THIS SUPPLY AND MANUFACTURING AGREEMENT (THE “SUPPLY AGREEMENT”) is made effective as of the 1st day of March, 2008 (the “Effective Date”) by and between Cerus Corporation (“Cerus”), a Delaware corporation, having its principal place of business at 2411 Stanwell Drive, Concord, CA 94520, and Porex Corporation (“Porex”), a Delaware corporation, having its principal place of business at 500 Bohannon Road, Fairburn, GA 30213. (Cerus and Porex are each individually referred to in this Supply Agreement as a “Party” and, collectively, as the “Parties”).
FIRST AMENDMENT TO SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • November 1st, 2018 • Cerus Corp • Surgical & medical instruments & apparatus
This First Amendment (“Amendment”) to the Supply and Manufacturing Agreement dated April 1, 2017 between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”) (the “Agreement”) is made this 22 day of June 2018.
SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • August 4th, 2017 • Cerus Corp • Surgical & medical instruments & apparatus • New York
This Amended and Restated Supply and Manufacturing Agreement (the “Supply Agreement”) is made effective as of the 1st day of April, 2017 (the “Effective Date”) by and between Cerus Corporation (“Cerus”), a Delaware corporation, having its principal place of business at 2550 Stanwell Drive, Concord, CA 94520, and Porex Corporation (“Porex”), a Delaware corporation, having its principal place of business at 500 Bohannon Road, Fairburn, GA 30213. (Cerus and Porex are each individually referred to in this Supply Agreement as a “Party” and, collectively, as the “Parties”).
SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • March 5th, 2024 • Cerus Corp • Surgical & medical instruments & apparatus • New York
This Amended and Restated Supply and Manufacturing Agreement (the “Supply Agreement”) is made effective as of the 1st day of April, 2017 (the “Effective Date”) by and between Cerus Corporation (“Cerus”), a Delaware corporation, having its principal place of business at 2550 Stanwell Drive, Concord, CA 94520, and Porex Corporation (“Porex”), a Delaware corporation, having its principal place of business at 500 Bohannon Road, Fairburn, GA 30213. (Cerus and Porex are each individually referred to in this Supply Agreement as a “Party” and, collectively, as the “Parties”).
FIRST AMENDMENT TO Supply and Manufacturing AgreementSupply and Manufacturing Agreement • April 30th, 2007 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
THIS AMENDMENT, dated as of this 24th day of April, 2007, by and between Teikoku Seiyaku Co., Ltd./Teikoku Pharma USA, Inc. (collectively, “TEIKOKU”) and ENDO PHARMACEUTICALS INC. (“ENDO”).
AXOGEN PROPRIETARY AND CONFIDENTIAL AXOGUARD HA+ NERVE PROTECTOR SUPPLY AND MANUFACTURING AGREEMENT THIS SUPPLY AND MANUFACTURING AGREEMENT (this “Agreement”) is entered into as of the 2nd day of May 2023 (“Effective Date”) by and between Cook Biotech...Supply and Manufacturing Agreement • March 5th, 2024 • Axogen, Inc. • Electromedical & electrotherapeutic apparatus • Indiana
SECOND AMENDMENT TO THE SUPPLY AND MANUFACTURING AGREEMENT BETWEEN TEIKOKU SEIYAKU CO., LTD./TEIKOKU PHARMA USA, INC. AND ENDO PHARMACEUTICALS INC.Supply and Manufacturing Agreement • January 11th, 2010 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
This Second Amendment (“Second Amendment”) to the Supply and Manufacturing Agreement is between Endo Pharmaceuticals Inc. (“Endo”) and Teikoku Seiyaku Co., Ltd (“Teikoku Japan”) and its U.S. subsidiary, Teikoku Pharma USA, Inc. (“Teikoku USA”) (collectively herein after referred to as “Teikoku”) and Endo Pharmaceuticals Inc. (“Endo”) dated as of November 23, 1998 and as amended as of April 24, 2007 (“First Amendment”), and is effective as of December 16th 2009.
ContractSupply and Manufacturing Agreement • March 8th, 2017 • Cerus Corp • Surgical & medical instruments & apparatus
This Amendment #3 (this “Amendment”) to that certain Supply and Manufacturing Agreement, dated March 1, 2008, by and between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”), as amended on November 28, 2012 and December 23, 2014 (together, the “Amendments”) (as amended by the Amendments, the “Agreement”), is made as of December 20, 2016. Capitalized terms used herein and not otherwise defined shall have the meanings set forth therefor in the Agreement.
SECOND AMENDED AND RESTATED SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • February 26th, 2025 • Cerus Corp • Surgical & medical instruments & apparatus • New York
This Second Amended and Restated Supply and Manufacturing Agreement (the “Supply Agreement” or “Agreement”) is made effective as of the 1st day of January, 2025 (the “Effective Date”) by and between Cerus Corporation (“Cerus”), a Delaware corporation, having its principal place of business at 1220 Concord Ave, Concord, CA 94520, and Porex Corporation (“Porex”), a Delaware corporation, having its principal place of business at 500 Bohannon Road, Fairburn, GA 30213. (Cerus and Porex are each individually referred to in this Supply Agreement as a “Party” and, collectively, as the “Parties”).
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.Supply and Manufacturing Agreement • March 16th, 2015 • Cerus Corp • Surgical & medical instruments & apparatus
THIS AMENDMENT #2 (this “Amendment 2”) to that certain Supply and Manufacturing Agreement, dated March 1, 2008, by and between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”), as amended on November 28, 2012 ( “Amendment 1”) (as amended by Amendment 1, the “Agreement”), is made as of December 23, 2014. Capitalized terms used herein and not otherwise defined shall have the meanings set forth therefor in the Agreement.
SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • April 7th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
FIRST AMENDMENT TO SUPPLY AND MANUFACTURING AGREEMENTSupply and Manufacturing Agreement • March 5th, 2024 • Cerus Corp • Surgical & medical instruments & apparatus
This First Amendment (“Amendment”) to the Supply and Manufacturing Agreement dated April 1, 2017 between Cerus Corporation (“Cerus”) and Porex Corporation (“Porex”) (the “Agreement”) is made this 22 day of June 2018.
